277 related articles for article (PubMed ID: 29335855)
1. T cell responses to tumor: how dominant assumptions on immune activity led to a neglect of pathological functions, and how evolutionary considerations can help identify testable hypotheses for improving immunotherapy.
Kallikourdis M
Cancer Immunol Immunother; 2018 Jun; 67(6):989-998. PubMed ID: 29335855
[TBL] [Abstract][Full Text] [Related]
2. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy.
Kumar A; Chamoto K; Chowdhury PS; Honjo T
Elife; 2020 Mar; 9():. PubMed ID: 32122466
[TBL] [Abstract][Full Text] [Related]
3. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
Front Immunol; 2018; 9():1990. PubMed ID: 30298063
[TBL] [Abstract][Full Text] [Related]
4. Specificity in cancer immunotherapy.
Schietinger A; Philip M; Schreiber H
Semin Immunol; 2008 Oct; 20(5):276-85. PubMed ID: 18684640
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the role of CD4
Tay RE; Richardson EK; Toh HC
Cancer Gene Ther; 2021 Feb; 28(1-2):5-17. PubMed ID: 32457487
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
Hosseinkhani N; Derakhshani A; Kooshkaki O; Abdoli Shadbad M; Hajiasgharzadeh K; Baghbanzadeh A; Safarpour H; Mokhtarzadeh A; Brunetti O; Yue SC; Silvestris N; Baradaran B
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167514
[TBL] [Abstract][Full Text] [Related]
7. Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors.
Leko V; Rosenberg SA
Cancer Cell; 2020 Oct; 38(4):454-472. PubMed ID: 32822573
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral immunotherapy: using the tumor as the remedy.
Marabelle A; Tselikas L; de Baere T; Houot R
Ann Oncol; 2017 Dec; 28(suppl_12):xii33-xii43. PubMed ID: 29253115
[TBL] [Abstract][Full Text] [Related]
9. [Development of immunotherapy for cancer: lessons from melanoma research].
Kawakami Y
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):87-98. PubMed ID: 15164929
[TBL] [Abstract][Full Text] [Related]
10. The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy.
Ganjoo S; Gupta P; Corbali HI; Nanez S; Riad TS; Duong LK; Barsoumian HB; Masrorpour F; Jiang H; Welsh JW; Cortez MA
Front Immunol; 2023; 14():1172931. PubMed ID: 37180129
[TBL] [Abstract][Full Text] [Related]
11. T-cell-based breast cancer immunotherapy.
Pilipow K; Darwich A; Losurdo A
Semin Cancer Biol; 2021 Jul; 72():90-101. PubMed ID: 32492452
[TBL] [Abstract][Full Text] [Related]
12. Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response.
Garris CS; Luke JJ
Clin Cancer Res; 2020 Aug; 26(15):3901-3907. PubMed ID: 32332013
[TBL] [Abstract][Full Text] [Related]
13. Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation.
Ellmark P; Mangsbo SM; Furebring C; Norlén P; Tötterman TH
Cancer Immunol Immunother; 2017 Jan; 66(1):1-7. PubMed ID: 27714433
[TBL] [Abstract][Full Text] [Related]
14. T cell recognition of human tumors: implications for molecular immunotherapy of cancer.
Ioannides CG; Whiteside TL
Clin Immunol Immunopathol; 1993 Feb; 66(2):91-106. PubMed ID: 8453790
[TBL] [Abstract][Full Text] [Related]
15. CXCR6 is required for antitumor efficacy of intratumoral CD8
Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
[TBL] [Abstract][Full Text] [Related]
16. Strategies of antigen-specific T-cell-based immunotherapy for cancer.
Liu SH; Zhang M; Zhang WG
Cancer Biother Radiopharm; 2005 Oct; 20(5):491-501. PubMed ID: 16248765
[TBL] [Abstract][Full Text] [Related]
17. Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
Bedognetti D; Ceccarelli M; Galluzzi L; Lu R; Palucka K; Samayoa J; Spranger S; Warren S; Wong KK; Ziv E; Chowell D; Coussens LM; De Carvalho DD; DeNardo DG; Galon J; Kaufman HL; Kirchhoff T; Lotze MT; Luke JJ; Minn AJ; Politi K; Shultz LD; Simon R; Thórsson V; Weidhaas JB; Ascierto ML; Ascierto PA; Barnes JM; Barsan V; Bommareddy PK; Bot A; Church SE; Ciliberto G; De Maria A; Draganov D; Ho WS; McGee HM; Monette A; Murphy JF; Nisticò P; Park W; Patel M; Quigley M; Radvanyi L; Raftopoulos H; Rudqvist NP; Snyder A; Sweis RF; Valpione S; Zappasodi R; Butterfield LH; Disis ML; Fox BA; Cesano A; Marincola FM;
J Immunother Cancer; 2019 May; 7(1):131. PubMed ID: 31113486
[TBL] [Abstract][Full Text] [Related]
18. Immune based therapies in cancer.
Krüger C; Greten TF; Korangy F
Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies.
Tun AM; Ansell SM
Cancer Treat Rev; 2020 Aug; 88():102042. PubMed ID: 32521386
[TBL] [Abstract][Full Text] [Related]
20. An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol.
Qomlaqi M; Bahrami F; Ajami M; Hajati J
Math Biosci; 2017 Oct; 292():1-9. PubMed ID: 28713023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
